Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

First and second generation cephalosporins

R Quintiliani, M French, C H Nightingale

    The Medical Clinics of North America
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Observation of a mixed close-packed structure in superionic water.

    Nature communications·2025
    Same author

    Metallization of Shock-Compressed Liquid Ammonia.

    Physical review letters·2021
    Same author

    Laser-driven shock compression of "synthetic planetary mixtures" of water, ethanol, and ammonia.

    Scientific reports·2019
    Same author

    Comment on "Isochoric, isobaric, and ultrafast conductivities of aluminum, lithium, and carbon in the warm dense matter regime".

    Physical review. E·2019
    Same author

    Weaning practices in phenylketonuria vary between health professionals in Europe.

    Molecular genetics and metabolism reports·2019
    Same author

    Early feeding practices in infants with phenylketonuria across Europe.

    Molecular genetics and metabolism reports·2018
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Understanding drug tissue levels is crucial for infection treatment. Future research aims to link drug dosing strategies with clinical effectiveness by correlating pharmacologic principles and tissue concentrations.

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Drug Delivery

    Background:

    • Tissue drug concentrations are vital for assessing efficacy at infection sites.
    • Uncertainty exists regarding optimal drug administration: rapid high levels (bolus) versus sustained lower levels (infusion).

    Purpose of the Study:

    • To explore the significance of drug tissue levels in infection treatment.
    • To address the debate between bolus and constant infusion drug administration strategies.
    • To guide future research in correlating drug dosing with clinical outcomes.

    Main Methods:

    • This study focuses on theoretical considerations and data interpretation regarding drug tissue levels.
    • No specific experimental methods are detailed; it's a conceptual overview.

    Related Experiment Videos

    Main Results:

    • The abstract does not present specific experimental results.
    • It highlights the importance of tissue drug concentration data.

    Conclusions:

    • Further research is needed to correlate pharmacologic principles with dosing regimens and tissue levels.
    • Establishing this correlation will optimize drug administration for improved clinical outcomes in infections.